Today I give an update on MDGL and ADMS that have shown some weakness. I also go into details on the AIMT phase 3 trial PALISADE, which I was confident would succeed.
Here is my AIMT position:
NOTE: This is not investment advice. This is only my opinion and you should do your own research before making any financial decisions.